BMS Looks To Utilize Cash Reserves To Break Into Japan's Top Tier
This article was originally published in The Pink Sheet Daily
Executive Summary
Ranked 14th in pharma sales globally, the company isn't even among the top 20 pharmacos in Japan--but it plans on a change in portfolio mix and an emphasis on business development activities to change that profile.